Current trends in N-acetyltransferase research arising from the 2007 International NAT Workshop

Pharmacogenomics

Volumn 9, Issue 6, 2008, Pages 765-771

  Boukouvala, Sotiria ^a   Westwood, Isaac M ^b   Butcher, Neville J ^c   Fakis, Giannoulis ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Arylamine N acetyltransferase; Enzyme function; Epidemiology; Eukaryotic NAT; Gene nomenclature; Gene regulation; Genomics; International workshop; Prokaryotic NAT; Protein structure

Indexed keywords

ACYLTRANSFERASE; ACYLTRANSFERASE INHIBITOR; ARYLAMINE ACETYLTRANSFERASE; BENZIDINE; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ALLERGY; ANTIBACTERIAL ACTIVITY; ASTHMA; BACTERIAL GROWTH; BLADDER CANCER; BREAST CANCER; CIGARETTE SMOKING; CONFERENCE PAPER; DRUG TARGETING; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; EUKARYOTE; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOMICS; GREECE; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; HUMAN; INTERNATIONAL COOPERATION; KIDNEY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL EXPERT; MEDICAL RESEARCH; MOUTH CANCER; MYCOBACTERIUM BOVIS; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROKARYOTE; PROTEOMICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; STRUCTURAL GENOMICS; TOXICOGENETICS; UTERINE CERVIX CANCER; WORKSHOP; ANIMAL; CHEMICAL STRUCTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SPECIES DIFFERENCE;

EUKARYOTA; PROKARYOTA;

ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BIOMEDICAL RESEARCH; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MODELS, MOLECULAR; SPECIES SPECIFICITY;

EID: 48949119316     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.6.765     Document Type: Conference Paper

References (27)

1. Sim E, Westwood I, Fullam E: Arylamine N-acetyltransferases. Expert Opin. Drug. Metab. Toxicol. 3(2), 169-184 (2007).
2. Minchin RF, Hanna PE, Dupret J-M, Wagner CR, Rodrigues-Lima F. Butcher NJ: Arylamine N-acetyltransferase 1. Int. J. Biocbem. Cell Biol. 39(11), 1999-2005 (2007).
3. Ilett KF, Kadlubar FF. Minchin RF: 1998 International meeting on the arylamine N-acetyltransferases: synopsis of the workshop on nomenclature, biochemistry, molecular biology, interspecies; comparisons and role in human disease risk. Drug Metab. Dispos. 27(9), 957-959 (1999).
4. Rodrigues-Lima F, Blömeke B, Sim E, Dupret J-M: NAT - from bugs to brains: An overview of the 2nd International Workshop on the arylamine N-acetyltransferases. Pharmacogenomics J. 2(3), 152-155 (2002).
5. McQueen C: Summary of the third annual workshop on arylamine N-acetyltransferases. ISSX Newsletter 24 (3), 13 (2004).
6. Wu H, Dombrovsky L, Tempel W et al.: Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J. Biol. Chem. 282 (41), 30189-30197 (2007).
7. 364A (D122N) genetic polymorphisms in human N-acetyltransferase 2. Pharmacogenet. Genomics 17(1), 37-45 (2007).
8. Zang Y, Doll MA, Zhao S. States JC. Hein DW: Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. Curinogenesis 28(8), 1665 1671 (2007).
9. Pluvinage B, Dairou J, Possot OM et al.: Cloning and molecular cheracterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance. Biochemistry 46(23), 7069-7078 (2007).
10. Fullam E, Westwood IM, Anderton MC, Lowe ED, Sim E, Noble EM: Divergence of cofactor recognition across evolution: Coenzyme A binding in a prokaryotic arylamine N-acetyltransferase. J. Mol. Biol. 375(1), 178-191 (2008).
11. Van der Geize R, Yam K, Heuser T et al.: A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Myrobacterium tuberculosis survival in macrophages. Proc. Natl Acad. Sci. USA 104(6), 1947-1952 (2007).
12. Boukouvaia S. Fakis G: Arylamine N-acetyltransferases: What we learn from genes and genomes. Drug Metab. Rev. 37(3), 511-564 (2005).
13. Fakis G, Boukouvala S, Kawamura A, Kennedy S: Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis. Pharmacogenet. Genomics 17(3), 181-188 (2007).
14. Prowse AH, Fakis G, Manek S et al.: Allelic loss studies do not provide evidence for the 'endometriosis-as-tumor' theory. Fertil. Steril. 83 (Suppl. 1), 1134-1143 (2005).
15. Walraven JM, Doll MA, Hein DW: Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2. J. Pharmacol. Exp. Ther. 319(1), 369-375 (2006).
16. Walraven JM, Barker DF, Doll MA, Hein DW: Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and functional characterization of a novel rNat3*2 genetic variant. Toxicol. Sci. 99(2), 413-421 (2007).
17. Wakefield L, Cornish V, Long H et al.: Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: A potential marker for the developing neuroendocrine system. Biomarkers 13(1), 106-118 (2008).
18. Wakefield L. Cornish V, Long H, Griffiths WJ. Sim E: Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism. Biochem. Biophys. Res. Commun. 364(3). 556-560 (2007).
19. Wakefield L, Long H, Lack N, Sim E: Ocular defects associated with a null mutation in the mouse arylamine? N-acetyltransferase 2 gene. Mamm. Genome 18(4), 270-276 (2007).
20. Wakefield L, Robinson J, Long H et al.: Arylamine N-acetyltransferase I expression in breast cancer cell lines: potential marker in estrogen receptor-positive tumors. Genes Chromosomes Cancer 47(2), 118-126 (2008).
21. Butcher NJ, Tetlow NL, Cheung C et al.: Induction of human arylamine N-acetyltransferase type I by androgens In human prostate cancer cells. Cancer Res. 67(1), 85-92 (2007).
22. Golka K, Blaszkewicz M, Samimi M, Bolt HM, Selinski S: Reconstruction of N-acetyltransferase 2 haplotypes using PHASE. Arch. Toxicol. 82(4), 265-270 (2008).
23. Majumder M, Sikdar N. Ghosh S. Roy B: Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int. J. Cancer 120(10). 2148-2156 (2007).
24. Batra J. Sharma SK, Ghosh B: Arylamine, N-acetyltransferase gene polymorphisms: Markers for atopic asthma, serum IgE and blood eosinophil counts. Pharmacogenomics 7(5), 673-682 (2006).
25. Hein DW. Boukouvala S. Grant DM, Minchin RF, Sim E: Changes in consensus arylamine N-acetyltransferase (NAT) gene nomenclature. Pharmacogenet. Genomics 18(4), 367-368 (2008).
26. Sandy J, Mushtaq A, Kawamura A, Sinclair J, Sim E, Noble M: The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis - an enzyme which inactivates the anti-tubercular drug isoniazid. J. Mol. Biol. 318(4), 1071-1083 (2002).
27. Potterton L. McNicholas S, Krissinel E et al.: Developments in the CCP4 molecular-graphics project. Acta Crystallogr. D Biol. Crystallogr. 60(12 Pt 1), 2288-2294 (2004).